![The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline | Markets Insider The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline | Markets Insider](https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2012/biotech2_2.jpg)
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline | Markets Insider
![Skepticism Greets Rare Disease Drug Maker CANbridge in Hong Kong IPO - Bamboo Works - China stock insights for global investors Skepticism Greets Rare Disease Drug Maker CANbridge in Hong Kong IPO - Bamboo Works - China stock insights for global investors](https://thebambooworks.com/wp-content/uploads/2021/12/CANbridge-1217-1.jpg)
Skepticism Greets Rare Disease Drug Maker CANbridge in Hong Kong IPO - Bamboo Works - China stock insights for global investors
![Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal](http://media.bizj.us/view/img/4563671/fred-eshelman-2*1200xx3957-2968-22-0.jpg)
Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal
![The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO](https://s.yimg.com/ny/api/res/1.2/jubXZmdd9M5HZUVoqFRZdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQyNw--/https://cdn2.benzinga.com/files/imagecache/600x400xUP/images/story/2012/medical-563427_1920_108.jpg)
The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO
![Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal](http://media.bizj.us/view/img/4563671/fred-eshelman-2*320xx1977-2968-2017-0.jpg)
Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal
![PBYI - Puma Biotechnology, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS) PBYI - Puma Biotechnology, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS)](https://images.fintel.io/us-pbyi-so.png)
PBYI - Puma Biotechnology, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS)
![Puma Biotechnology, Inc. (NASDAQ:PBYI) Forecasted to Earn FY2023 Earnings of $0.49 Per Share - MarketBeat Puma Biotechnology, Inc. (NASDAQ:PBYI) Forecasted to Earn FY2023 Earnings of $0.49 Per Share - MarketBeat](https://www.marketbeat.com/logos/puma-biotechnology-inc-logo-1200x675.jpg?v=20221216145125)
Puma Biotechnology, Inc. (NASDAQ:PBYI) Forecasted to Earn FY2023 Earnings of $0.49 Per Share - MarketBeat
![Alan H. Auerbach - Founder, Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile Alan H. Auerbach - Founder, Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile](https://images.crunchbase.com/image/upload/c_pad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1498388026/lvjklczpmuxg486pm7q6.jpg)
Alan H. Auerbach - Founder, Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile
![Rare Securities Class Action Lawsuit Trial Results in Partial Verdict for Plaintiffs | The D&O Diary Rare Securities Class Action Lawsuit Trial Results in Partial Verdict for Plaintiffs | The D&O Diary](https://www.dandodiary.com/wp-content/uploads/sites/893/2019/02/puma.jpg)
Rare Securities Class Action Lawsuit Trial Results in Partial Verdict for Plaintiffs | The D&O Diary
![PBYI - Puma Biotechnology, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS) PBYI - Puma Biotechnology, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS)](https://images.fintel.io/us-pbyi-put-call-ratio.png)